References
- Ko JY, Farr SL, Dietz PM, et al. Depression and treatment among U.S. pregnant and nonpregnant women of reproductive age, 2005-2009. J Womens Health. 2012;21:830–836.
- Vesga-Lopez O, Blanco C, Keyes K, et al. Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psych. 2008;65:805–815.
- Eberhard‐Gran M, Eskild A, Tambs K, et al. Review of validation studies of the Edinburgh postnatal depression scale. Acta Psychiatr Scand. 2008;104(4):243–249.
- Sokol DK. “First do no harm” revisited. Br Med J. 2013;347:f6426.
- National Institute for Health and Care Excellence. Antenatal and postnatal mental health: clinical management and service guidance. Clinical guideline [CG192]; 2014 December 17. [cited 2020 Dec 12].
- Gelenberg AJ, Freeman MP, Markowitz JC, et al. American Psychiatric Association practice guideline for the treatment of patients with major depressive disorder, third edition. Washington, DC. Am Psych Association. 2010;167:1–152.
- Raffi E, Nonacs R, Cohen LS. Safety of psychotropic medications during pregnancy. Clin Perinatal. 2019;46:215–234.
- Lassen D, Ennis ZN, Damkier P. First-trimester pregnancy exposure to venlafaxine or duloxetine and risk of major congenital malformations: a systematic review. Basic Clin Pharmacol Toxicol. 2016;118:32–36.
- Godman B, Kurdi A, McCabe H, et al. Ongoing initiatives within the Scottish national health service to affect the prescribing of selective serotonin reuptake inhibitors and their influence. J Comp Eff Res. 2019;8(7):535–547. .
- Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391:1357–1366.
- Godman B, Marie Persson M, Miranda J, et al. Changes in the utilization of venlafaxine after the introduction of generics in Sweden. Appl Health Econ Health Policy. 2013;11:383–393.
- Miller LJ. Use of electroconvulsive therapy during pregnancy. Hosp Comm Psych. 1994;45(5):444–450.
- Kim DR, Epperson N, Pare E, et al. An open label pilot study of transcranial magnetic stimulation for pregnant women with major depressive disorder. J Womens Health. 2011;20(2):255–261.